Tyra Bioscience (TYRA)
NASDAQ:TYRA
US Market
Holding TYRA?
Track your performance easily

Tyra Bioscience (TYRA) Financial Statements

45 Followers

Tyra Bioscience Financial Overview

Tyra Bioscience's market cap is currently ―. The company's EPS TTM is $-1.691; its P/E ratio is -14.40; Tyra Bioscience is scheduled to report earnings on October 31, 2024, and the estimated EPS forecast is $-0.40. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -18.70M$ -18.19M$ -25.63M$ -21.15M$ -13.27M
EBITDA$ -18.58M$ -18.07M$ -25.53M-$ -13.19M
Net Income Common Stockholders$ -18.70M$ -18.19M$ -22.83M$ -21.15M$ -13.27M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 373.80M$ 382.46M$ 203.47M$ 215.65M$ 232.41M
Total Assets$ 392.46M$ 404.74M$ 225.86M$ 238.36M$ 250.01M
Total Debt$ 6.40M$ 6.49M$ 6.50M$ 6.11M$ 6.07M
Net Debt$ -367.40M$ -375.98M$ -196.97M$ -209.54M$ -226.34M
Total Liabilities$ 16.42M$ 14.86M$ 21.59M$ 16.19M$ 11.44M
Stockholders Equity$ 376.04M$ 389.88M$ 204.26M$ 222.17M$ 238.57M
Cash Flow-
Free Cash Flow$ -10.73M$ -22.16M$ -14.13M-$ -9.66M
Operating Cash Flow$ -10.26M$ -22.03M$ -13.53M$ -17.14M$ -9.62M
Investing Cash Flow$ -144.99M$ 18.07M$ -144.44M$ -83.00K$ -43.00K
Financing Cash Flow$ 373.00K$ 200.31M$ 324.00K$ 467.00K$ 370.00K
Currency in USD

Tyra Bioscience Earnings and Revenue History

Tyra Bioscience Debt to Assets

Tyra Bioscience Cash Flow

Tyra Bioscience Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis